These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 38376799)

  • 1. [Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics].
    Hoffmann AS; Betz CS; Böscke R; Weber RK
    HNO; 2024 Apr; 72(4):225-230. PubMed ID: 38376799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic rhinosinusitis with nasal polyps management in the age of biologics.
    Blaiss MS
    Allergy Asthma Proc; 2020 Nov; 41(6):413-419. PubMed ID: 33109306
    [No Abstract]   [Full Text] [Related]  

  • 3. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP.
    Guo CL; Liu FF; Wang DY; Liu Z
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):703-713. PubMed ID: 37987873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Difficult-to-treat chronic rhinosinusitis-when the standard treatment is not effective and biologics are not available].
    Böscke R
    HNO; 2024 Apr; 72(4):231-241. PubMed ID: 38472346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era.
    Heffernan A; Phulka J; Thamboo A
    J Otolaryngol Head Neck Surg; 2022 May; 51(1):22. PubMed ID: 35606866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil.
    Anselmo-Lima WT; Tamashiro E; Romano FR; Miyake MM; Roithmann R; Kosugi EM; Nakanishi M; Fornazieri MA; Bezerra TFP; Mello JF; Lessa MM; Voegels RL; Piltcher OB; Sakano E; Valera FCP
    Braz J Otorhinolaryngol; 2022; 88(3):471-480. PubMed ID: 33867274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
    Bachert C; Desrosiers MY; Hellings PW; Laidlaw TM
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1099-1106. PubMed ID: 33227522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52.
    Bachert C; Khan AH; Lee SE; Hopkins C; Peters AT; Fokkens W; Praestgaard A; Radwan A; Nash S; Jacob-Nara JA; Deniz Y; Rowe PJ
    Int Forum Allergy Rhinol; 2024 Mar; 14(3):668-678. PubMed ID: 37548085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation.
    Jin Z; Yan B; Zhang L; Wang C
    Expert Opin Investig Drugs; 2023; 32(10):909-919. PubMed ID: 37855222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
    Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
    Favier V; Daveau C; Carsuzaa F; Fieux M; Vandersteen C; Castillo L; Papon JF; de Gabory L; Saroul N; Verillaud B; Rumeau C; Jankowski R; Michel J; de Bonnecaze G; Lecanu JB; Coste A; Béquignon E; Malard O; Mortuaire G
    BMJ Open; 2024 May; 14(5):e083112. PubMed ID: 38749694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
    Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
    HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
    Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
    Okano M; Kanai K; Oka A
    Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience of biological therapy in severe forms of chronic rhinosinusitis with nasal polyps in the conditions of regional healthcare].
    Larin RA; Mokeeva PP; Grishin AS
    Vestn Otorinolaringol; 2023; 88(2):51-58. PubMed ID: 37184555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis.
    Han JK; Bachert C; Lee SE; Hopkins C; Heffler E; Hellings PW; Peters AT; Kamat S; Whalley D; Qin S; Nelson L; Siddiqui S; Khan AH; Li Y; Mannent LP; Guillemin I; Chuang CC
    Laryngoscope; 2022 Feb; 132(2):265-271. PubMed ID: 34850966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID-exacerbated respiratory disease.
    Xu X; Reitsma S; Wang Y; Fokkens WJ
    Allergy; 2022 Dec; 77(12):3593-3605. PubMed ID: 36067036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.